Betta Pharmaceuticals Co Ltd (300558)

Shenzhen

Currency in CNY

50.48

+1.52(+3.10%)

Closed·30/09

Fair Value

Unlock Value

Day's Range

48.50

51.26

52 wk Range

40.10

78.18

300558 Income Statement

Featured here, the Income Statement (earnings report) for Betta Pharmaceuticals Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2022

01/01

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

2,245.86

2,376.63

2,456.2

2,891.95

3,609.34

Total Revenues Growth

aa.aa

+20.08%

+5.82%

+3.35%

+17.74%

+24.81%

Cost Of Revenues

aa.aa

174.44

268.69

404.48

538.52

738.66

Gross Profit

aa.aa

2,071.42

2,107.94

2,051.71

2,353.43

2,870.68

Gross Profit Growth

aa.aa

+19.64%

+1.76%

-2.67%

+14.71%

+21.98%

Gross Profit Margin %

aa.aa

92.23%

88.69%

83.53%

81.38%

79.53%

Other Operating Expenses, Total

aa.aa

1,722.65

1,900.98

1,771.83

1,876.47

2,330.23

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+30.84%	+10.35%	-6.79%	+5.91%	+24.18%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	565.95	699.9	640.14	501.9	510.87
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,141.46	1,235.58	1,121.07	1,356.38	1,778.48
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	15.24	-34.51	10.62	18.19	40.88

Operating Income

aa.aa

348.77

206.96

279.88

476.96

540.45

Operating Income Growth

aa.aa

-15.92%

-40.66%

+35.24%

+70.41%

+13.31%

EBIT Margin %

aa.aa

15.53%

8.71%

11.39%

16.49%

14.97%

Net Interest Expenses

aa.aa

17.58

-184.92

-44.72

-38.71

-71.84

Net Interest Expenses Growth

aa.aa

-93.2%

-1,152.12%

+75.82%

+13.44%

-85.6%

Interest Expense, Total

aa.aa

-15.78

-195.8

-54.95

-45.49

-76.14

Interest And Investment Income

aa.aa

33.35

10.88

10.23

6.78

4.29

Other Non Operating Expenses, Total

aa.aa

-4.47

0.55

1.76

-2.43

-13.81

EBT, Excl. Unusual Items

aa.aa

361.88

22.59

236.92

435.82

454.79

Gain (Loss) On Sale Of Assets

aa.aa

0.07

88.61

-0.01

-0.59

0.38

Other Unusual Items, Total

aa.aa

26.98

-3.01

98.83

-0.1

38.52

EBT, Incl. Unusual Items

aa.aa

389.93

87.57

322.07

394.16

414.36

EBT, Incl. Unusual Items Growth

aa.aa

-41.51%

-77.54%

+267.79%

+22.38%

+5.13%

EBT, Incl. Unusual Items Margin

aa.aa

17.36%

3.68%

13.11%

13.63%

11.48%

Income Tax Expense

aa.aa

10.37

-37.19

-11.54

7.18

128.15

Net Income to Company

aa.aa

379.56

124.76

333.62

386.98

286.21

Minority Interest

aa.aa

3.51

20.66

14.42

15.59

19.12

Net Income

aa.aa

383.07

145.42

348.03

402.57

305.33

Net Income Growth

aa.aa

-36.83%

-62.04%

+139.33%

+15.67%

-24.15%

Net Income Margin %

aa.aa

17.06%

6.12%

14.17%

13.92%

8.46%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

383.07

145.42

348.03

402.57

305.33

Basic EPS - Continuing Operations

aa.aa

0.92

0.35

0.83

0.96

0.73

Basic EPS - Continuing Operations Growth

aa.aa

-38.67%

-62.01%

+137.47%

+15.66%

-23.96%

Diluted EPS - Continuing Operations

aa.aa

0.92

0.35

0.83

0.96

0.73

Diluted EPS - Continuing Operations Growth

aa.aa

-38.26%

-62.01%

+137.47%

+15.66%

-23.96%

Basic Weighted Average Shares Outstanding

aa.aa

416.38

416.06

419.32

419.34

418.26

Diluted Weighted Average Shares Outstanding

aa.aa

416.38

416.3

419.32

419.34

418.26

Dividend Per Share

aa.aa

0.25

0.07

0.17

0.2

0.15

Dividend Per Share Growth

aa.aa

-19.35%

-72%

+142.86%

+17.65%

-25%

EBITDA

aa.aa

517.89

453.58

578.14

845.1

1,088.38

EBITDA Growth

aa.aa

-9.13%

-12.42%

+27.46%

+46.17%

+28.79%

EBITDA Margin %

aa.aa

23.06%

19.08%

23.54%

29.22%

30.15%

EBIT

aa.aa

348.77

206.96

279.88

476.96

540.45

* In Millions of CNY (except for per share items)

FAQ

What was Betta Pharmaceuticals Co’s revenue at year end?

At the end of the last reported fiscal year, Betta Pharmaceuticals Co (300558) recorded total revenue of 3,609.34 million CNY.

How much revenue did Betta Pharmaceuticals Co report in the most recent quarter?

In its most recent quarterly earnings report, Betta Pharmaceuticals Co posted revenue of 936.09 million CNY.

What was Betta Pharmaceuticals Co’s net income for the year?

For the full year, Betta Pharmaceuticals Co reported net income of 305.33 million CNY.

How much net income did Betta Pharmaceuticals Co post in the last quarter?

In the most recent quarter, Betta Pharmaceuticals Co (300558) posted net income of 66.22 million CNY.

What was Betta Pharmaceuticals Co’s gross profit for the year?

Gross profit for the year was reported at 2,870.68 million CNY.

How much gross profit did Betta Pharmaceuticals Co generate last quarter?

Betta Pharmaceuticals Co recorded gross profit of 687.96 million CNY in its latest quarterly report.

What was Betta Pharmaceuticals Co’s annual operating income?

For the full year, Betta Pharmaceuticals Co (300558) reported operating income of 540.45 million CNY.

What was Betta Pharmaceuticals Co’s operating income last quarter?

Quarterly operating income was 81.04 million CNY.

What was Betta Pharmaceuticals Co’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 220.30 million CNY.

What was the quarter-over-quarter change in EBITDA for Betta Pharmaceuticals Co?

EBITDA changed by -49.16% million CNY compared to the last quarter.

What is Betta Pharmaceuticals Co’s most recent gross profit margin?

The latest reported gross profit margin for Betta Pharmaceuticals Co (300558) is 73.49% million CNY.

What is Betta Pharmaceuticals Co’s most recent net income margin?

Net income margin based on recent financials is 7.07% million CNY.

What is Betta Pharmaceuticals Co’s most recent EBIT margin?

Betta Pharmaceuticals Co reported an EBIT margin of 8.66% million CNY based on current figures.

How did Betta Pharmaceuticals Co’s revenue change compared to the previous quarter?

Revenue changed by -9.98% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Betta Pharmaceuticals Co?

In the latest quarter, gross profit changed by -16.34% million CNY from the previous quarter.

PSEi Composite

5,648.09

+18.62

+0.33%

Nikkei 225

68,350.00

-606.72

-0.88%

Shanghai

3,842.19

+11.74

+0.31%

US 500

7,685.40

+18.7

+0.24%

US Tech 100

30,616.70

+115.1

+0.38%

DAX

24,939.35

-259.84

-1.03%

Dollar Index

101.76

-0.123

-0.12%

Market Movers

Name	Last	Chg. %	Vol.
International Container	872.000	+0.58%	346.06K
Ayala	515.50	-1.43%	479.61K
BDO Unibank	110.50	+0.18%	1.22M
Universal Robina	56.90	-1.04%	1.73M
SM Investments	492.80	+0.16%	145.87K
Philex Mining A	11.100	-0.18%	4.72M
Bank of the Philippine Islands	94.10	-0.42%	401.81K

Name	Last	Chg. %	Vol.
IPM	1.990	+13.71%	2.00K
DFNN	0.650	+6.56%	1.00K
DigiPlus Interactive	8.000	+5.96%	1.79M
Manila Electric	434.40	+4.12%	38.01K
Cebu Air	19.060	+3.93%	119.60K
Upson International	0.78	+4.00%	28.00K
COL Financial	1.59	+3.92%	150.00K

Name	Last	Chg. %	Vol.
Pacifica	1.510	-8.48%	34.00K
Everwoods Green	0.0260	-7.14%	1.90M
Supercity Realty Dev	30.80	-6.95%	300.00
Pryce	17.800	-5.72%	41.50K
Island Information Tech	0.1230	-4.65%	60.00K
LBC Express	10.300	-6.36%	1.30K
Global-Estate Resorts	0.660	-4.35%	20.00K

Trending Stocks

Name	Last	Chg. %	Vol.
International Container	872.000	+0.58%	346.06K
Metropolitan Bank	61.00	+0.08%	197.42K
BDO Unibank	110.50	+0.18%	1.22M
SM Investments	492.80	+0.16%	145.87K
Manila Electric	434.40	+4.12%	38.01K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaaaaaa	13.74	+68.37%	23.17
Aaaaaaaaa Aaaa	8.82	+60.05%	14.08
Aaaaaaa	5.640	+57.95%	8.908
Aaa Aa	492.80	+56.68%	775.58
Aaaaaaaaa Aa	18.100	+56.47%	28.353
Aa Aaaaaa	1.670	+55.20%	2.607
Aa Aaaaaaaaa Aaaa A	425.00	+54.02%	653.05

Name	Last	Upside	Fair Value
Aa Aaaaaaaaaaa	13.74	+68.37%	23.17
Aaaaaaaaa Aaaa	8.82	+60.05%	14.08
Aaaaaaa	5.640	+57.95%	8.908
Aaa Aa	492.80	+56.68%	775.58
Aaaaaaaaa Aa	18.100	+56.47%	28.353
Aa Aaaaaa	1.670	+55.20%	2.607
Aa Aaaaaaaaa Aaaa A	425.00	+54.02%	653.05

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Betta Pharmaceuticals Co Ltd (300558)

300558 Income Statement

FAQ

What was Betta Pharmaceuticals Co’s revenue at year end?

How much revenue did Betta Pharmaceuticals Co report in the most recent quarter?

What was Betta Pharmaceuticals Co’s net income for the year?

How much net income did Betta Pharmaceuticals Co post in the last quarter?

What was Betta Pharmaceuticals Co’s gross profit for the year?

How much gross profit did Betta Pharmaceuticals Co generate last quarter?

What was Betta Pharmaceuticals Co’s annual operating income?

What was Betta Pharmaceuticals Co’s operating income last quarter?

What was Betta Pharmaceuticals Co’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Betta Pharmaceuticals Co?

What is Betta Pharmaceuticals Co’s most recent gross profit margin?

What is Betta Pharmaceuticals Co’s most recent net income margin?

What is Betta Pharmaceuticals Co’s most recent EBIT margin?

How did Betta Pharmaceuticals Co’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Betta Pharmaceuticals Co?

Trending Stocks